SSP120 Antibody

What is SSP120 and what is its function in cellular processes?

Ssp120 is a luminal protein that functions in the early secretory pathway. Research demonstrates that Ssp120 is efficiently packaged into COPII vesicles (approximately 13-15% incorporation rate) and maintains a steady-state Golgi localization . Since Ssp120 lacks known vesicle trafficking signals and is confined to the lumen, it relies on association with transmembrane proteins like Emp47 for selective COPII-vesicle packaging . This interaction is critical for maintaining appropriate levels of Ssp120 in the cell, as deletion of Emp47 drastically reduces steady-state levels of Ssp120 (to approximately 16% of wild-type levels) .

How can I detect SSP120 in experimental samples?

Ssp120 can be detected using both epitope-tagged versions (e.g., Ssp120-HA) and with polyclonal antibodies raised against the native protein. Immunoblotting is an effective technique for detecting Ssp120 in cell lysates, microsomes, and COPII vesicles . When using epitope tags, it's important to verify that the tag doesn't affect the protein's behavior - research has confirmed that HA-tagged Ssp120 is incorporated into COPII vesicles at similar levels (13%) to the native protein (14%), indicating the tag doesn't disrupt normal trafficking .

What controls should I include when using SSP120 antibodies in immunoblotting?

When conducting immunoblotting with SSP120 antibodies, include the following controls:

• Negative control: Include samples from ssp120Δ strains to confirm antibody specificity

• Loading control: Use a consistently expressed protein unrelated to the secretory pathway

• Specificity control: Include CPY (carboxypeptidase Y) as a negative control for co-immunoprecipitation experiments

• Positive control: Include wild-type samples with known Ssp120 expression levels

How do I optimize immunoprecipitation protocols for studying SSP120 interactions?

For effective immunoprecipitation of Ssp120 and its interaction partners:

• Sample preparation: Prepare budding-competent microsomes from appropriate strains (wild-type or tagged Ssp120)

• Solubilization: Use Triton X-100 to solubilize membranes while preserving protein-protein interactions

• Antibody selection: For tagged versions, use monoclonal anti-HA antibodies; for native protein, use polyclonal anti-Ssp120 antibodies

• Validation: Confirm specificity by comparing results from wild-type and deletion strains

• Interaction analysis: Analyze co-precipitated bands by mass spectrometry for identification of novel interaction partners

This approach successfully identified the near-stoichiometric interaction between Ssp120 and Emp47, which was confirmed by immunoblotting with anti-Emp47 antibodies .

What methods are effective for analyzing SSP120 trafficking in the secretory pathway?

To analyze Ssp120 trafficking, researchers can employ several complementary approaches:

• In vitro COPII budding assays: These assays measure the incorporation efficiency of Ssp120 into COPII vesicles by comparing the percentage of protein in vesicle fractions versus total microsomes

• Immunofluorescence microscopy: Determine subcellular localization using fluorescently labeled antibodies

• Fractionation studies: Separate cellular compartments to track Ssp120 distribution

• Secretion assays: Measure extracellular Ssp120 levels using TCA-precipitation of culture medium followed by immunoblotting

Research shows that disruption of the Ssp120-Emp47 interaction (e.g., in emp47Δ strains) results in reduced intracellular Ssp120 levels and increased extracellular secretion, indicating a defect in retention within the secretory pathway .

How does the Ssp120-Emp47 complex formation affect experimental design when studying either protein?

When studying either Ssp120 or Emp47, it's critical to consider their interdependent relationship:

• Asymmetric dependency: Ssp120 levels and proper localization depend heavily on Emp47, but Emp47 levels and packaging efficiency remain relatively unaffected in ssp120Δ strains

• Experimental implications:

  • When studying Ssp120, always assess Emp47 status

  • For Emp47 studies, consider effects on Ssp120 as potential downstream consequences

  • In knockout/knockdown experiments, the loss of one protein may indirectly affect pathways through its impact on the partner protein

This relationship creates a direction-specific dependency where experiments targeting Emp47 will have more dramatic effects on the Ssp120-Emp47 system than those targeting Ssp120 directly .

What considerations are important when developing new antibodies against SSP120?

When developing new SSP120 antibodies, researchers should consider:

• Epitope selection: Choose unique regions that don't cross-react with related proteins

• Validation strategy: Plan validation using both positive controls (wild-type cells) and negative controls (ssp120Δ strains)

• Antibody format: Consider whether polyclonal or monoclonal antibodies better suit the research needs

• Purification approach: For polyclonal antibodies, affinity purification using recombinant Ssp120 can improve specificity

• Cross-species reactivity: If studying Ssp120 homologs in other organisms, assess conservation of epitopes

Properly validated antibodies should show specific immunoreactivity in wild-type samples and no signal in deletion strains, as demonstrated for the anti-Ssp120 polyclonal antibody in previous research .

Why might I observe variable detection of SSP120 in different cell fractions?

Variable detection of Ssp120 across different cell fractions can occur for several reasons:

• Emp47 dependency: Since Ssp120 levels depend on Emp47, any condition affecting Emp47 expression or localization will impact Ssp120 detection

• Trafficking dynamics: Ssp120 continuously cycles between ER and Golgi, making its distribution sensitive to secretory pathway perturbations

• Technical factors:

  • Incomplete solubilization of membranes

  • Antibody access limitations in different subcellular compartments

  • Protein degradation during sample preparation

When troubleshooting, compare Ssp120 detection with that of established markers for different compartments (ER, Golgi, vesicles) and consider the Emp47 status in your experimental system .

How can I distinguish between specific and non-specific signals when using SSP120 antibodies?

To distinguish between specific and non-specific signals:

• Use genetic controls: Always include samples from ssp120Δ strains as negative controls

• Perform peptide competition assays: Pre-incubate antibodies with excess purified Ssp120 peptide to block specific binding

• Compare multiple antibodies: If possible, use different antibodies targeting distinct Ssp120 epitopes

• Molecular weight verification: Confirm signals appear at the expected molecular weight (~58-60 kDa for Ssp120)

• Signal intensity correlation: Verify that signal intensity correlates with expected Ssp120 expression levels across different conditions

Proper experimental design should include controls that allow clear differentiation between specific Ssp120 signals and background reactivity .

What are the optimal conditions for preserving SSP120-Emp47 interactions during experimental procedures?

To preserve the Ssp120-Emp47 interaction during experiments:

• Detergent selection: Use Triton X-100 for membrane solubilization as it effectively preserves the Ssp120-Emp47 interaction

• Buffer composition: Include appropriate protease inhibitors to prevent degradation

• Temperature control: Perform solubilization and immunoprecipitation steps at 4°C to minimize dissociation

• Time considerations: Minimize the time between cell lysis and analysis to prevent complex dissociation

• Antibody selection: Choose antibodies that don't interfere with the interaction interface

These conditions have successfully demonstrated the near-stoichiometric interaction between Ssp120 and Emp47 in immunoprecipitation experiments .

How can I quantitatively assess SSP120 incorporation into COPII vesicles?

For quantitative analysis of Ssp120 incorporation into COPII vesicles:

• In vitro budding assay setup:

  • Prepare microsomal membranes from appropriate strains

  • Incubate with cytosol, GTP, and an ATP regeneration system to generate COPII vesicles

  • Separate vesicles from donor membranes by centrifugation

• Quantification approach:

  • Analyze equal proportions of total microsomes (T) and COPII vesicles (V)

  • Perform immunoblotting with anti-Ssp120 antibodies

  • Include controls for COPII vesicle formation (e.g., Erv29) and negative controls (e.g., Sec61)

  • Calculate packaging efficiency as the percentage of signal in vesicle fraction relative to total microsomes

• Data interpretation:

  • Normal Ssp120 packaging efficiency is approximately 13-15% in wild-type cells

  • Reduced packaging efficiency may indicate defects in the Ssp120-Emp47 interaction or COPII vesicle formation

This methodology has revealed that Emp47 is required for efficient incorporation of Ssp120 into COPII vesicles .

How might single-cell analysis techniques be applied to study SSP120 dynamics?

Single-cell analysis techniques offer promising approaches for studying Ssp120 dynamics:

• Live-cell imaging: Using fluorescently tagged Ssp120 to track its movement through the secretory pathway in real-time

• FRAP analysis: Fluorescence recovery after photobleaching to measure Ssp120 mobility and retention within cellular compartments

• Single-molecule tracking: Following individual Ssp120 molecules to understand heterogeneity in trafficking behaviors

• Mass cytometry: Using metal-labeled antibodies to quantify Ssp120 levels across heterogeneous cell populations

• Spatial transcriptomics: Correlating Ssp120 protein localization with local mRNA expression patterns

These approaches could provide insights into the dynamic regulation of Ssp120 trafficking that are not captured by population-level biochemical assays currently employed in the field .

What are the implications of SSP120-Emp47 interaction for studying other luminal-transmembrane protein pairs?

The Ssp120-Emp47 interaction provides a model for studying other luminal-transmembrane protein pairs:

• Conceptual framework: Demonstrates how luminal proteins lacking sorting signals can achieve specific localization through interactions with transmembrane partners

• Methodological approach: Provides a template for identifying and characterizing similar interactions using co-immunoprecipitation and vesicle budding assays

• Evolutionary considerations: Suggests selective pressure for the co-evolution of interacting protein pairs in the secretory pathway

• Disease relevance: May provide insights into pathologies resulting from disrupted protein-protein interactions in the secretory pathway

• Therapeutic potential: Could inform strategies for manipulating protein trafficking through targeting specific interactions

This research paradigm could be extended to identify and characterize other luminal proteins that rely on transmembrane partners for proper localization and function .